Compounds > 1-methyl-4-phenylpyridinium
Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Malignant Melanoma

1-methyl-4-phenylpyridinium has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, Y; Nagatsu, T; Naoi, M; Ohashi, M; Ohya, Y; Umemura, T; Yasue, T1
Fujita, K; Ito, S; Nagatsu, T; Naoi, M; Takahashi, T1

Other Studies

2 other study(ies) available for 1-methyl-4-phenylpyridinium and Malignant Melanoma

ArticleYear
Selective toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) to pigmented melanoma cells in vitro.
    Anti-cancer drug design, 1991, Volume: 6, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Formazans; Humans; In Vitro Techniques; Melanins; Melanoma; Oxidation-Reduction; Pigmentation; Tumor Cells, Cultured

1991
Accumulation of N-methyl-4-phenylpyridinium ion (MPP+) in human melanoma cell line, HMV-I and -II.
    Neuroscience letters, 1988, Apr-22, Volume: 87, Issue:1-2

    Topics: 1-Methyl-4-phenylpyridinium; beta-Galactosidase; Cell Line; Dihydroxyphenylalanine; Dopamine; Humans; Melanins; Melanoma; Proteins; Pyridinium Compounds; Tumor Cells, Cultured

1988